AJMC Staff

Coverage of our peer-reviewed research and news reporting in the health care and mainstream press.

FDA is expected to recommend a plan on distribution of COVID-19 booster shots to immunocompromised Americans; California becomes the first state to issue a vaccine mandate for its health care workers; exploring the threat of COVID-19 infection in pediatric populations.

The Biden administration looks into requiring foreign visitors to be fully vaccinated against COVID-19; subsidies generated from the American Rescue Plan led to savings on premiums for coverage through the Affordable Care Act (ACA); a federal review is under way on the controversial approval of the Alzheimer drug aducanumab (Aduhelm).

FDA reportedly aims to fully approve Pfizer-BioNTech COVID-19 vaccine by early next month; Biogen’s Alzheimer drug sees little uptake; majority of Americans over 65 have received at least 1 dose of a COVID-19 vaccine.

Seventy percent of Americans have received at least 1 dose of a COVID-19 vaccine; CMS releases payment rules for fiscal year 2022; alcohol linked to over 700,000 new cancer diagnoses in 2020.

Florida sets record for daily COVID-19 cases and hospitalizations; spotlighting health equity in the workplace; delineating COVID-19 hotspots where masking is recommended.

The latest news in rheumatology includes the need for robust vaccinations in juvenile idiopathic arthritis; new findings about rheumatoid arthritis (RA) and type 2 diabetes; and quality of life in systemic lupus erythematosus.

In an interim analyses of the phase 3 SEQUOIA trial, zanubrutinib had superior progression-free survival compared with bendamustine plus rituximab in patients with treatment-naive chronic lymphocytic leukemia (CLL) or small lymphocytic leukemia (SLL).

Coverage of our peer-reviewed research and news reporting in the health care and mainstream press.

A new CMS rule increases reimbursement for providers; coffee is linked to decreased risk of arrhythmia; the Johnson & Johnson COVID-19 vaccine’s shelf life is extended.

President Joe Biden requires federal workers to get vaccinated for COVID-19 or face strict safety protocols; Pfizer files federal lawsuit over reimbursing drugs through Medicare; and the CDC revises its testing guidance for fully vaccinated individuals.

Americans traveling to England will no longer need to quarantine; lack of ICU visits during COVID-19 pandemic affected patient health; sign-up window for COBRA subsidy to close.

The Department of Justice (DOJ) and HHS issue joint guidance indicating that long COVID-19 can be classified as a disability; the Department of Veterans Affairs (VA) becomes the first federal agency to implement a COVID-19 vaccination mandate for some workers; federal regulators push for expansion of COVID-19 vaccine trials in children to better assess safety.

Links between COVID-19 brain fog and risk of Alzheimer disease; cigarette manufacturer Philip Morris International discusses plans to stop selling cigarettes in the United Kingdom; COVID-19 vaccine adverse effects are more likely in people previously infected with the virus.

The issue of reactivating hepatitis B and other chronic viruses such as herpes zoster after treatment for myeloproliferative neoplasms (MPN) is an emerging issue in hematologic malignancies, due to the power of newer therapies.

Coverage of our peer-reviewed research and news reporting in the health care and mainstream press.

Mississippi's attorney general asks the Supreme Court to overturn Roe v Wade; the Biden administration releases more COVID-19 funds to combat the delta variant; Missouri Supreme Court rules to expand health care access.

The federal government requires insurers to cover PrEP; Johnson & Johnson (J&J) and pharmaceutical wholesalers agree to settle opioid crisis lawsuits; NYC health care workers will be required to receive a vaccine or weekly tests for COVID-19.

COVID-19 cases and deaths rise as Delta variant spreads; Lowest life expectancy since 2003; US medical debt nearly doubles in 4 years.

CMS proposes rule on price transparency and emergency care access in rural communities and health care gaps exacerbated by the pandemic; wildfire smoke is associated with increased susceptibility to COVID-19; American Academy of Pediatrics recommends mask mandates in schools.

New cases of COVID-19 are rising in all 50 states for the third consecutive day; stark increase in alcohol-associated liver disease hospitalizations reported amid the pandemic; nearly 2 dozen reports of mysterious health incidents have been observed among US personnel in Vienna, Austria.

An advisory from the US Surgeon General classifies COVID-19 misinformation as a public health threat; the most populous county in the nation reinstates a mask mandate; debate continues around COVID-19 booster shots.

Coverage of our peer-reviewed research and news reporting in the health care and mainstream press.

Two big health systems will not administer a newly approved drug to patients to treat Alzheimer disease; drug overdose deaths hit a new high in 2020 Johnson & Johnson (J&J) recall sunscreen products after detecting a cancer-causing chemical.

CMS proposes update to Medicare Physician Fee Schedule; patients with rare diseases struggle to gain expanded access to experimental treatments; a coalition of health care organizations calls on facilities to require the COVID-19 vaccine for workers.

HHS officials say that fully vaccinated individuals do not need to get a booster shot; FDA issues a warning on link between the Johnson & Johnson vaccine and a rare neurological condition; California counties sue pesticide manufacturer over widely used bug killer that may cause brain damage in children and fetuses.

Treatment options for patients with these rare diseases have expanded in recent years, but rheumatologists may have limited experience with systemic vasculitis.

The CDC issues updated mask guidance for teachers and students in school buildings; alcohol abuse is on the rise; Anthony Fauci, MD, addresses concerns on the lack of full approval for COVID-19 vaccines.

An overview of the latest news in Parkinson disease reported across MJH Life Sciences™.